Variables | Adverse neonatal outcomes | |||||
---|---|---|---|---|---|---|
Frequency (%) | COR (95% CI) | AOR (95% CI) | p-value | |||
Yes | No | |||||
Onset of labor | Induced | 107(41.2%) | 153(58.8%) | 6.14(4.22, 8.93) * | 1. 89(1.11, 3.22) | 0.019 |
Spontaneous | 54(10.2%) | 474(89.8%) | 1 | 1 | ||
Maternal age | < 20 years | 18(26.9%) | 49(73.1%) | 1.66(0.93, 2.97) | 1.29(0.82,3.94) | > 0.1 |
20–34 years | 113(18.1%) | 512(81.9%) | 1 | 1 | ||
>=35 years | 30(31.3%) | 66(68.8%) | 2.06(1.278, 3.319) | 1.12(0.56, 2.27) | ||
Maternal educational status | No education | 70(29.7%) | 166(70.3%) | 2.021(1.2, 3.402) * | 2.00(1.56, 6.44) | 0.001 |
Primary | 35(16.7%) | 175(83.3%) | 0.958(0.542, 1.695) | 0.92(0.82, 3.76) | 0.144 | |
Secondary | 32(15.8%) | 171(84.2%) | 0.897(0.502, 1.601) | 0.87(0.83, 3.8) | 0.138 | |
> secondary | 24(17.3%) | 115(82.7%) | 1 | 1 | ||
Marital status | Single | 6(35.3%) | 11(64.7%) | 2.381(0.866, 6.549) | 0.45(0.10, 1.96) | > 0.3 |
Married | 137(18.6%) | 598(81.4%) | 1 | 1 | ||
Others | 18(50%) | 18(50%) | 4.37(2.21, 8.61) | 1.17(0.42, 3.21) | ||
Monthly income in ETB | < 500 | 53(28.5%) | 133(71.5%) | 1.94(1.20, 3.13) | 1.02(0.42, 2.47) | >0.6 |
500–1000 | 59(18.8%) | 255(81.2%) | 1.13(0.712, 1.78) | 0.91(0.43,1.94) | ||
1001–2000 | 13(16.9%) | 64(83.1%) | 0.99(0.49, 1.98) | 0.88(0.33,2.33) | ||
> 2000 | 36(17.1%) | 175(82.9%) | 1 | 1 | ||
Prenatal substance use | Yes | 39(33.1) | 79(66.9) | 2.22(1.44, 3.41) | 1.20(0.65, 2.22) | 0.55 |
No | 122(18.2%) | 548(81.8%) | 1 | 1 | ||
Chronic disease | Yes | 28(51.9%) | 26(48.9%) | 4.87(2.76, 8.57) | 3.99(1. 87, 8.52) | < 0.001 |
No | 133(18.1%) | 601(81.9%) | 1 | 1 | ||
Hx of malaria infection | Yes | 54(25.5%) | 158(74.5%) | 1.50(1.03, 2.18) | 0.85(0.50, 1.45) | 0.59 |
No | 107(18.6%) | 469(81.4%) | 1 | 1 | ||
Gravidity | Primigravida | 63(19.8%) | 255(80.2%) | 1.04 (0.71,1.51) | 0.48(0.11,2.14) | > 0.3 |
Multigravida | 74(19.2%) | 311(80.8%) | 1 | 1 | ||
Grandgravida | 24(28.2%) | 61(71.8%) | 1.65(0.97,2.83) * | 1.12(0.31, 3.98) | ||
Parity | Primipara | 66(20.8%) | 252(79.2%) | 1.20(0.82, 1.75) | 0.93(0.54, 1.60) | > 0.2 |
Multipara | 69(17.9%) | 316(82.1%) | 1 | 1 | ||
Grandpara | 26(30.6%) | 59(69.4%) | 2.02 (1.19,3.43) | 1.87(0.60, 5.84) | ||
ANC follow up | No | 7(50%) | 7(50%) | 4.03(1.39,11.65) | 1.96(0.49, 7.78) | 0.4 |
Yes | 154(19.9%) | 620(80.1%) | 1 | 1 | ||
Bad obstetric history | Yes | 48(36.9%) | 82(63.1%) | 2.82(1.82, 4.25) | 1.48(0.81, 2.72) | 0.2 |
No | 113(17.2%) | 545(82.8%) | 1 | 1 | ||
Iron folate supplement | No | 37(27.2%) | 99(72.8%) | 1.59(1.04, 2.44) | 0.67(0.34, 1.30) | 0.23 |
Yes | 124(19%) | 528(81%) | 1 | 1 | ||
Complication during Pregnancy | Yes | 77(40.5%) | 113(69.5%) | 4.17(2.88, 6.04) | 0.98(0.55, 1.74) | 0.95 |
No | 84(14%) | 514(86%) | 1 | 1 | ||
Male involvement | No | 39(39%) | 61(61%) | 2.96(1.90, 4.64) | 2.23 (1.23, 4.10) | 0.009 |
Yes | 122(17.7%) | 566(82.3%) | 1 | 1 | ||
Maternal Hgb | <= 10Â mg/dl | 14(53.8%) | 12(46.2%) | 4.88(2.21, 10.77) | 0.70(0.20, 2.46) | 0.58 |
>=11Â mg/dl | 147(19.3%) | 615(80.7%) | 1 | 1 | ||
Gestational age | Preterm | 18(75%) | 6(25%) | 14.07(5.48,36.16) | 9.83(8.74, 76.37) | < 0.001 |
Term | 126(17.6%) | 591(82.4%) | 1 | 1 | Â | |
Post term | 17(36.2%) | 30(63.8%) | 2.66(1.42, 4.97) | 2.43(1.23, 6.14) | 0.014 | |
MSAF | Yes | 76(42%) | 105(58%) | 4.45(3.06, 6.46) | 0.68(0.36, 1.25) | 0.21 |
No | 85(14%) | 522(86%) | 1 | 1 | ||
Mode of delivery | Instrumental | 61(56%) | 48(44%) | 12.39(7.76, 19.78) | 8.60(4.63,15.90) | < 0.001 |
CS | 44(57.1%) | 33(42.9%) | 13.00(7.66, 22.05) | 4.17(1.94, 8.95) | < 0.001 | |
SVD | 56(9.3%) | 546(90.7%) | 1 | 1 | Â | |
Complications during labor and delivery | Yes | 75(64.7%) | 41(35.3%) | 12.46(8.01, 19.41) | 5.16 (2.89, 9.18) | < 0.001 |
No | 86(12.8%) | 586(87.2%) | 1 | 1 |